Felgner J H, Kumar R, Sridhar C N, Wheeler C J, Tsai Y J, Border R, Ramsey P, Martin M, Felgner P L
VICAL Inc., San Diego, California 92121.
J Biol Chem. 1994 Jan 28;269(4):2550-61.
The application of cationic liposome reagents has advanced DNA and mRNA transfection research in vitro, and data are accumulating which show their utility for in vivo gene transfer. However, chemical structure-activity data leading to a better mechanistic understanding of their biological activity is still limited. Most of the cationic lipid reagents in use today for this application are formulated as liposomes containing two lipid species, a cationic amphiphile and a neutral phospholipid, typically dioleoylphosphatidylethanolamine (DOPE). The studies reported here examine the effects of some systematic chemical structural changes in both of these lipid components. Cationic and neutral phospholipids were formulated together as large multilamellar vesicles (MLV) or small sonicated unilamellar vesicles (SUV) in water, and each formulation was assayed quantitatively in 96-well microtiter plates under 64 different assay conditions using COS.7 cells and an RSV-beta-galactosidase expression plasmid. The cationic lipid molecules used for these studies were derived from a novel series of 2,3-dialkyloxypropyl quaternary ammonium compounds containing a hydroxyalkyl moiety on the quaternary amine. A homologous series of dioleylalkyl (C18:1) compounds containing increasing hydroxyalkyl chain lengths on the quaternary amine were synthesized, formulated with 50 mol % DOPE, and assayed for transfection activity. The order of efficacy was ethyl > propyl > butyl > pentyl > 2,3-dioleyloxypropyl-1-trimethyl ammonium bromide (DOTMA). DOTMA, which is commercially available under the trademark Lipofectin Reagent, lacks a hydroxyalkyl moiety on the quaternary amine. A homologous series of hydroxyethyl quaternary ammonium derivatives with different alkyl chain substitutions were synthesized, formulated with 50 mol % DOPE, and assayed in the transfection assay. The order of transfection efficacy was dimyristyl (di-C14:0) > dioleyl (di-C18:1) > dipalmityl (di-C16:0) > disteryl (di-C18:0). The addition of 100 microM chloroquine in the transfection experiment enhanced the activity of the dioleyl compound by 4-fold and decreased the activity of the dimyristyl compound by 70%. For each of the compounds and formulations examined in this report, large multilamellar vesicles (MLV; diameter 300-700 nm) were more active than small unilamellar vesicles (SUV; diameter 50-100 nm). The neutral phospholipid requirements for transfection activity in COS.7 cells with these cationic lipid molecules were examined.(ABSTRACT TRUNCATED AT 400 WORDS)
阳离子脂质体试剂的应用推动了体外DNA和mRNA转染研究的进展,并且越来越多的数据表明它们在体内基因转移方面具有实用性。然而,能够更好地从机理上理解其生物活性的化学结构-活性数据仍然有限。当今用于此应用的大多数阳离子脂质试剂都被配制成含有两种脂质的脂质体,一种是阳离子两亲物,另一种是中性磷脂,通常是二油酰磷脂酰乙醇胺(DOPE)。本文报道的研究考察了这两种脂质成分中一些系统性化学结构变化的影响。将阳离子和中性磷脂一起在水中配制成大的多层囊泡(MLV)或小的超声处理单层囊泡(SUV),并且在64种不同的测定条件下,使用COS.7细胞和RSV-β-半乳糖苷酶表达质粒,在96孔微量滴定板中对每种制剂进行定量测定。用于这些研究的阳离子脂质分子衍生自一系列新型的2,3-二烷氧基丙基季铵化合物,其季铵上含有一个羟烷基部分。合成了一系列在季铵上具有增加的羟烷基链长度的二油酰烷基(C18:1)化合物,与50摩尔%的DOPE一起配制,并测定其转染活性。效力顺序为乙基>丙基>丁基>戊基>2,3-二油酰氧基丙基-1-三甲基溴化铵(DOTMA)。DOTMA以Lipofectin Reagent商标在市场上销售,其季铵上缺少羟烷基部分。合成了一系列具有不同烷基链取代的羟乙基季铵衍生物,与50摩尔%的DOPE一起配制,并在转染试验中进行测定。转染效力顺序为二肉豆蔻基(二-C14:0)>二油酰基(二-C18:1)>二棕榈酰基(二-C16:0)>二硬脂酰基(二-C18:0)。在转染实验中添加100 microM氯喹可使二油酰基化合物的活性提高4倍,并使二肉豆蔻基化合物的活性降低70%。对于本报告中研究的每种化合物和制剂,大的多层囊泡(MLV;直径300-700nm)比小的单层囊泡(SUV;直径50-100nm)更具活性。研究了使用这些阳离子脂质分子在COS.7细胞中转染活性对中性磷脂的要求。(摘要截短至400字)